BIM

115.2

+1.5%↑

SRT3

228.5

-0.65%↓

GXI

55.15

+2.89%↑

ICAD

20.98

-1.04%↓

BIM

115.2

+1.5%↑

SRT3

228.5

-0.65%↓

GXI

55.15

+2.89%↑

ICAD

20.98

-1.04%↓

BIM

115.2

+1.5%↑

SRT3

228.5

-0.65%↓

GXI

55.15

+2.89%↑

ICAD

20.98

-1.04%↓

BIM

115.2

+1.5%↑

SRT3

228.5

-0.65%↓

GXI

55.15

+2.89%↑

ICAD

20.98

-1.04%↓

BIM

115.2

+1.5%↑

SRT3

228.5

-0.65%↓

GXI

55.15

+2.89%↑

ICAD

20.98

-1.04%↓

Search

Almirall SA

Abierto

SectorSanidad

9.65 1.15

Resumen

Variación precio

24h

Actual

Mínimo

9.49

Máximo

9.71

Métricas clave

By Trading Economics

Ingresos

-430K

-2.1M

Ventas

28M

258M

P/B

Media del Sector

187.4

57.333

BPA

0.04

Rentabilidad por dividendo

1.96

Margen de beneficios

-0.814

Empleados

2,026

EBITDA

3.9M

45M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+44.82% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.96%

2.63%

Próximas Ganancias

12 may 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-26M

2B

Apertura anterior

8.5

Cierre anterior

9.65

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

Almirall SA Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

10 dic 2024, 07:05 UTC

Charlas de Mercado

EU Specialty Pharma to See Product Launches But Limited Clinical Data Next Year -- Market Talk

Comparación entre iguales

Cambio de precio

Almirall SA previsión

Precio Objetivo

By TipRanks

44.82% repunte

Estimación a 12 Meses

Media 13.83 EUR  44.82%

Máximo 17 EUR

Mínimo 12 EUR

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Almirall SA Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

3 ratings

3

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

9.42 / 9.65Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Weak Bullish Evidence

Largo Plazo

Weak Bullish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Almirall SA

Almirall, S.A., a biopharmaceutical company, engages in the purchase, manufacture, storage, and sale of skin-health medicines in Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising actinic keratosis, atopic dermatitis, alopecia areata, skin cancer, psoriasis, onychomycosis, vitiligo, hidradenitis suppurativa, oncodermatology, acne, orphan indications, and rare skin diseases, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, respiratory, and nervous system; dermatologicals; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations. It has a multi-target alliance with Etherna to research and develop new mRNA-based therapies for severe skin diseases, including non-melanoma skin cancer. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.